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Abstract
Background:  The mammary gland undergoes a sophisticated programme of developmental
changes during pregnancy/lactation. However, little is known about processes involving initiation of
apoptosis at involution following weaning. We used fur seals as models to study the molecular
process of involution as these animals display a unique mammary gland phenotype. Fur seals have
long lactation periods whereby mothers cycle between secreting copious quantities of milk for 2
to 3 days suckling pups on land, with trips to sea alone to forage for up to 23 days during which
time mammary glands remain active without initiating apoptosis/involution.
Results: We show the molecular basis by which alpha-lactalbumin (LALBA), a secreted milk
protein, is absent in Cape fur seals and demonstrate an apoptotic function for LALBA when
exposed to mammary cells.
Conclusion: We propose that apoptosis does not occur in fur seal mammary glands due to lack
of LALBA in fur seal milk, allowing evasion of involution during a foraging trip. Our work identifies
LALBA as a milk factor that feeds back on the mammary gland to regulate involution.
Background
The mammary gland represents one of the most dramatic
examples of physiological development. The massive
changes of form and function of mammary glands over
the life span of a female are characterized by extreme
changes in cell proliferation, differentiation, secretion and
death, which accompanies pregnancy, lactation and invo-
lution upon weaning. While milk is sucked from the
mammary gland it provides nutrition and immunity to
the young. However, upon milk stasis, due to absence of
sucking at weaning, the mammary gland regresses and is
remodelled by a process known as involution, which
cleanses the gland and returns it to a virgin-like state.
Although the mammary gland appears vastly regulated it
is also highly susceptible to cancer, with mortality associ-
ated with breast cancer rating amongst the highest causes
of death for women in the western world.
The study of apoptosis in the mammary gland during
involution is important for understanding both the nor-
mal biology of post-natal regression and the events lead-
ing to mammary gland tumorigenesis. Interestingly, some
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mammals have modified their lactation cycle in order to
accommodate and adapt to extreme environmental pres-
sures. Animals such as otariid seals (fur seals and sea
lions) exhibit an unusual lactation phenotype [1] which
differs from other members of the Pinnipedia family and
other mammals. These animals display resistance to
mammary gland apoptosis and involution after cessation
of sucking, and provide a unique opportunity to investi-
gate aspects of mammary gland physiology that are
present but not readily apparent in other species.
The three families of Pinnipeds, comprising Phocids (true
seals), Odobenids (walrus), and Otariids (sea lions, fur
seals) evolved from a carnivorous ancestor around 25 mil-
lion years ago and diverged during the middle Miocene
(10 million years ago) [2]. Each family adopted different
approaches to lactation. Phocid seals evolved large sizes to
reduce heat loss and risk of predation and increase body
reserves. This enabled them to adopt a 'fasting strategy' of
lactation [3] whereby amassed body reserves of stored
nutrients facilitate fasting on land during continuous milk
production over relatively short periods (4 to 42 days,
depending on the species).
In contrast, ancestral otariid seals retained smaller body
sizes and insulating fur, and bred at rockeries to gain prox-
imity to local prey resources adopting a 'foraging lacta-
tion' strategy [1]. The small size of otariid seals made it
necessary to feed during lactation in order to replenished
body stores required to continue milk production.
Reduced prey availability led to lengthening of the lacta-
tion period (4 to > 12 months) and otariid seals began
exploiting resources farther off shore, increasing the dura-
tion but reducing frequency of foraging trips during lacta-
tion. The current-day otariid seals produce milk with no
detectable lactose [4,5] and have adopted a lactation strat-
egy which is characterized by alternation between periods
of several days of copious milk production on shore and
extended periods of maternal foraging at sea [1]. Inter-
suckling intervals have been recorded in otariid seals of up
to 23 days and are among the longest ever recorded for a
mammal [1]. The need to increase duration of foraging
trips due to distant foraging grounds during lactation has
selected for an adapted otariid mammary gland, which
remains functional despite sustained interruptions in
suckling activity.
For other mammals, accumulation of milk in the mam-
mary gland due to cessation of sucking by the young
allows factors present within milk to regulate mammary
epithelium, causing downregulation of milk protein gene
expression, followed by involution via apoptotic cell loss
[6]. During long periods at sea, in the absence of sucking,
fur seal mammary glands have been recorded to produce
80% less milk than when lactating on land [7], and milk
protein gene expression decreases [8], aspects which are
common with cessation of sucking in other mammalian
species and characteristic of the initiation of involution
[9]. In other mammals these events are rapidly followed
by involution comprising apoptotic mammary gland cell
death [9], but the fur seal mammary gland does not
undergo involution at this time [8] and remains active in
readiness for return to land to continue nursing the
young. The fur seal mammary gland evades the effects of
engorgement by downregulating milk protein produc-
tion; however, milk still remains in the gland. Therefore
these animals display resistance to mammary gland apop-
tosis and involution following cessation of suckling and
provide a unique opportunity to investigate aspects of
mammary gland physiology associated with involution.
There are many examples of genetic rearrangements that
show strong associations with specific phenotypes that
have important evolutionary consequences (see [10] for
examples). In many cases a gene required for the develop-
ment of a specific trait in one species shows a difference in
expression in other species that correlates with a different
trait [10]. These relationships provide causal evidence of
plausibility.
Here we show the alpha-lactalbumin gene (LALBA),
which normally encodes a milk protein involved in lac-
tose synthesis, has undergone a number of cis-acting
mutations, which render the protein absent in otariids.
We show that LALBA causes apoptosis of mouse and
human mammary epithelial cell lines and fur seal primary
mammary cells. We propose that lactose synthesis and
mammary gland involution does not normally occur in
fur seal mammary glands due to absence of LALBA in fur
seal milk and show that previous predictions based solely
on isolation of cDNA in otariid mammary glands [11] are
incorrect. We discuss and present functional evidence that
directly relates to the different lactation phenotypes of
otariid and phocid seals.
Results
LALBA gene expression in the fur seal mammary gland
Affymetrix canine arrays were used to examine the pattern
of gene expression in mammary tissue from Cape fur seals
(Arctocephalus pusillus) during pregnancy, on-shore lacta-
tion and off-shore lactation. These results were compared
with microarray analysis patterns of genes expressed in
human (Homo sapiens), cow (Bos taurus) and mouse (Mus
musculus) mammary gland during pregnancy and lacta-
tion. Using this approach candidate apoptosis genes were
examined for significant differences in expression, and
unusually low levels of a major milk protein gene, LALBA,
were observed in mammary glands of lactating Cape fur
seals.BMC Biology 2008, 6:48 http://www.biomedcentral.com/1741-7007/6/48
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In human, cow and mouse lactation cycles, LALBA expres-
sion levels were found to be similar to that of other milk
protein genes (146%, 68% and 96% expression relative to
β-casein) and levels of expression of both these milk pro-
tein genes increased dramatically with onset of lactation
(Figure 1A). In Cape fur seal lactation, expression of
LALBA was observed to only increase slightly from preg-
nancy to lactation and was expressed at only 0.8% of the
level of the β-casein gene (Figure 1A). Due to differences in
probe sets on the Affymetrix chips, the observed low level
of Cape fur seal LALBA  expression relative to β-casein
expression, and the lack of LALBA induction from preg-
nancy to lactation, was validated by RT-PCR using RNA
extracted from mammary glands of on-shore, off-shore
and pregnant seals (Figure 1B). Interspecies comparison
therefore revealed Cape fur seal LALBA was expressed at
0.5%, 1.1% and 0.8% of the levels observed in human,
cow and mouse mammary glands, respectively, during
lactation.
Further analysis was performed by RT-PCR using RNA
extracted from lactating mammary gland tissue from pig,
mouse and wallabies using LALBA  primers specific for
each species. The wallaby was included in this analysis
due to the absence of lactose in wallaby milk during peak
lactation. Compared with pigs, mice and wallabies, Cape
fur seals were found to have a 10 to 100-fold reduction in
LALBA expression during lactation (Figure 1C).
In order to determine the abundance of LALBA transcripts
relative to all other transcripts within the lactating fur seal
mammary gland we undertook a large-scale global tran-
scriptome analysis. 11,232 EST clones from a Cape fur seal
lactating mammary gland were sequenced and annotated.
A single LALBA  gene transcript failed to be detected,
whereas mRNAs representing other milk protein genes κ-
casein,  β-casein, casein αS1-casein  and  αS2-casein  were
detected at high levels (Figure 1D).
Comparative promoter analysis
Comparative otariid and phocid LALBA promoter analysis
and gene expression studies were undertaken to elucidate
the differences between LALBA expression in these highly
related species with distinctly different lactation pheno-
types. Genomic DNA upstream from the untranslated
region of the LALBA gene of three otariid seals, Cape fur
LALBA comparative expression Figure 1
LALBA comparative expression. (A) Affymetrix analysis of LALBA and β-casein transcripts in human, cow, mouse and Cape 
fur seal mammary glands during pregnancy (black bar) and lactation (grey bar). (B) RT-PCR quantitative analysis of LALBA and β-
casein expression in Cape fur seal mammary glands during pregnancy (black bar), lactation on-shore (dark grey bar) and lacta-
tion off-shore (light grey bar). (C) Interspecies RT-PCR quantitative analysis of LALBA expression levels in mammary glands of 
Cape fur seal, pig, mouse and wallaby during peak lactation. (D) Milk protein gene transcripts (from a total of 11,232 ESTs) 
sequenced from Cape fur seal lactating mammary gland. Standard errors are shown.
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seal, California sea lion (Zalophus californianus) and Ant-
arctic fur seal (A. gazella,) was amplified, sequenced and
compared with three phocid seals; grey seal (Halichoerus
grypus), ringed seal (Pusa hispida) and harbour seal (Phoca
vitulina). Analysis of a 718 bp region of the immediate
proximal promoter for all seal species showed 96.78 to
97.21% sequence identity, suggesting high level of conser-
vation. However, the TATA box, a conserved DNA
sequence which initiates transcription in many genes
[12], and previously defined for the LALBA gene in guinea
pigs at positions -60 to -57 (relative to the start of tran-
scription) [13] was altered in all three otariid seals. All
three otariid species displayed a T-G transversion within
the third position of the TATA box, creating an AAGAAA
sequence (Figure 2). The LALBA TATA box in many other
mammalian species comprises the sequence AATAAA,
with the exception of mouse and human which comprise
CATAAA and TATAAA respectively (Table 1).
In vitro expression analysis
A direct comparison between otariid and phocid LALBA
gene expression levels was assayed by use of reporter gene
constructs. This was performed in order to determine if
low levels of Cape fur seal LALBA transcript detection were
due to low levels of LALBA  gene transcription or low
LALBA transcript stability.
Regions of genomic DNA containing LALBA promoters
and translation initiation codons (ATG) of an otariid seal
(Cape fur seal) and a phocid seal (harbour seal) were
ligated into to a luciferase reporter gene. For both species
the immediate -718 bp to 3 bp promoter fragment was
cloned in front of a luciferase gene within a basic vector
(pGL3) and promoter activity was measured by tran-
siently transecting plasmids into a bovine mammary epi-
thelial cell line (BME-UV1) and a human embryonic
kidney cell line (HEK293T) and measuring luciferase
activity under a variety of conditions. BME-UV1 cells,
which have previously been shown to induce expression
of milk protein gene promoters in the presence of lac-
togenic hormones [14], were used to examine both basal
and inducible LALBA expression levels, while HEK293T
cells were used to measure LALBA expression in the pres-
ence of an introduced enhancer element, measuring the
capacity of the TATA box to initiate transcription. In BME-
UV1 cells, significant expression levels failed to be
detected for both seal species so a STAT5 site was subse-
quently introduced by in vitro mutagenesis (Figure 2) to
enhance LALBA expression, as previously described for
the mouse LALBA promoter [15]. With the addition of the
STAT5 site, the harbour seal LALBA reporter constructs
showed significantly higher levels of expression in BME-
UV1 cells under non-induced (insulin) and induced con-
ditions (insulin, prolactin, dexamethazone), compared
with the Cape fur seal LALBA  reporter constructs (P  =
0.038) (Figure 3A), similar to that shown for the mouse
LALBA promoter in the presence of an introduced SAT5
site [15]. The influence of the otariid TATA box (AAGAAA)
on gene transcription was analysed by correcting the Cape
fur seal TATA box (AAGAAA to AATAAA) using in vitro
mutagenesis to introduce a T into the G position. The in
vitro mutated Cape fur seal TATA box (AATAAA) alone
failed to significantly increase levels of transcription com-
pared with the wild-type Cape fur seal (AAGAAA) pro-
moter construct in the presence of the introduced STAT5
site. Each promoter was also assayed in BME-UV1 cells
using an enhancer sequence (pGL3-Enhancer) to elevate
basal transcription levels. Again the harbour seal LALBA
reporter constructs showed significantly higher levels of
expression compared with the Cape fur seal LALBA
reporter constructs (P = 0.000) and the in vitro mutated
Cape fur seal TATA box (AATAAA) alone failed to signifi-
cantly increase levels of transcription compared with the
wild-type Cape fur seal (AAGAAA) promoter construct
(Figure 3B). The LALBA::luciferase  constructs were also
tested in HEK293T cells with the same results (Figure 3C).
Use of different host cell lines eliminated the probability
that the observed expression pattern was not cell-line spe-
cific. These results showed that the low level of Cape fur
seal LALBA expression observed occurred at the level of
transcription and was not due to low LALBA transcript sta-
bility. These results also showed that the Cape fur seal
LALBA TATA mutation alone is not responsible for the
low level of expression observed (Figure 3A to 3C).
Identification of LALBA transcripts
The LALBA gene was previously found to contain a muta-
tion in the 3' splice site of intron 3 causing incorrect splic-
ing of the third exon giving rise to two transcripts [11].
Due to the very low level of expression of otariid LALBA it
is difficult to identify the number and full range of LALBA
transcripts. In order to determine the nature and relative
abundance of different LALBA splice variants of the ota-
riid seals (Cape fur seal, California sea lion and Antarctic
fur seal) and phocid seals (ringed seal and harbour seal),
LALBA genomic fragments were cloned into CMV expres-
sion vectors and transfected into HEK293T cells. Genomic
fragments comprised all 4 exons and 3 introns with
3'UTR. Following transfection, analysis of LALBA  tran-
scripts by RT-PCR and sequence analysis showed the pres-
ence of one major otariid LALBA  transcript,
corresponding to LALBA(s), with the structure exon 1–2–
3 and lacking exon 4, and two minor transcripts (Figure
4A). One of the two minor transcripts corresponded to
LALBA(l) with the structure exon 1–2–3, intron 3 exon 4,
while the second minor transcript LALBA(Δ) is due to
incorrect splicing of intron 1 leading to deletion of the
final 60 bp in intron 1. This deletion is caused by use of a
5' splice consensus sequence (AAT/GTGAGCT) withinBMC Biology 2008, 6:48 http://www.biomedcentral.com/1741-7007/6/48
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Comparative analysis of the Pinnipedia LALBA promoter Figure 2
Comparative analysis of the Pinnipedia LALBA promoter. Comparison of nucleotide sequences of the immediate 
upstream promoter regions of the pinniped LALBA gene shows very strong conservation of nucleotide sequences among spe-
cies. Divergent bases are shaded. Dashes represent gaps in the alignment. Nucleotide positions are shown relative to the start 
of translation (BOLD). A number of predicted binding sites are indicated. The 'milk box' [RGAAGRAA(N)TGGACAGAAAT-
CAA(CG)TTTCTA] previously identified in LALBA and casein promoter sequences were also present at an identical position in 
the pinniped LALBA genes. The base involved in the Cape fur seal G to T mutagenesis to correct the predicted TATA box from 
AAGAAA to AATAA is shown by an asterisk, and bases involved in creation of a STAT5 site by converting CAAn6GAT to 
CAAn6GAA via mutagenesis in harbour seal and Cape fur seal are underlined. GS: grey seal, RS: ringed seal, HS: harbour seal, 
CFS: cape fur seal, AFS: Antarctic fur seal, CSL: California sea lion.
GS  -416 CTAGGGGAAGGGGGTTTTGGCCATGGACCCTTATTTTATTTTCTGATTGCCTCACTCAT 
RS  -416 CTAGGGGAAGGGGGTTTTGGCCATGGACCCTTATTTTATTTTCTGATTGCCTCACTCAT 
HS  -416 CTAGGGGAAGGGGGTTTTGGCCATGGACCCTTATTTTATTTTCTGATTGCCTCACTCAT 
CFS -416 CTAGGGGAAGGGGGTTTTGGCCATGGACTCTTCTTTTATTTTCTGATTGCCTCACTCAT 
AFS -416 CTAGGGGAAGGGGGTTTTGGCCATGGACTCTTCTTTTATTTTCTGATTGCCTCACTCAT 
CSL -416 CTAGGGGAAGGGGGTTTTGGCCATGGACTCTTCTTTTATTTTCTGATTGCCTCACTCAT 
GS      ATTATCCCTGAGGCCTCCTTTGTTCCTGAAGTAGGCTGGGGACATCCTGCTTCCTAGAAA 
RS      ATTATCCCTGAGGCCTCCTTTGTTCCTGAAGTAGGCTGGGGACATCCTGCTTCCTAGAAA 
HS      ATTATCCCTGAGGCCTCCTTTGTTCCTGAAGTAGGCTGGGGACATCCTGCTTCCTAGAAA 
CFS     ATTACCTCTGAGGCCTCCTTTGTTCCTGAAGTAGGCTGGAGACATCCTGCTTCCTAGAAC 
AFS     ATTACCTCTGAGGCCTCCTTTGTTCCTGAAGTAGGCTGGAGACATCCTGCTTCCTAGAAC 
CSL     ATTACCTCTGAGGCCTCCTTTGTTCCTGAAGTAGGCTGGAGACAACCTGCTTCCTAGAAC 
GS      CAAATCTACAAGAAACAAAAGTACAAAAAAGCCAAATGGGAAGAGATTCATGTTTGAAAC 
RS      CAAATCTACAAGAAACAAAAGTACAAAAAAGCCAAATGGGAAGAGATTCATGTTTGAAAC 
HS      CAAATCTACAAGAAACAAAAGTACAAAAAAGCCAAATGGGAAGAGATTCATGTTTGAAAC 
CFS     CAAATCTACAAGAAACAAAAGTACAAAAAAGCCAAATGGGAAGAGATTCATGTTTGAAAC 
AFS     CAAATCTACAAGAAACAAAAGTACAAAAAAGCCAAATGGGAAGAGATTCATGTTTGAAAC 
CSL     CAAATCTACAAGAAACAAAAGTACAAAAAAGCCAAATGGGAAGAGATTCATGTTTGAAAC 
GS      TCTGGGCAGAAAACAATACTTGTATGGACTAGAGATTAGGGGAGGAGTAGGAAAAACAGG 
RS      TCTGGGCAGAAAACAATACTTGTATGGACTGGAGATTAGGGGAGGAGTAGGAAAAACAGG 
HS      TCTGGGCAGAAAACAATACTTGTATGGACTAGAGATTAGGGGAGGAGTAGGAAAAACAGG 
CFS     TCTGGGCAGAAAACAATACTTGTATGGACTAGAGATTAGGGGAAGAGAAGGAAAAATGGG 
AFS     TCTGGGCAGAAAACAATACTTGTATGGACTAGAGATTAGGGGAAGAGAAGGAAAAATGGG 
CSL     TCTGGGCAGAAAACAATACTTGTATGGACTAGAGATTAGGGGAAGAGAAGGAAAAATGGG 
GS      GTAAAAGTACGGAAGGAAGTTTGGCAGGCTTAGTGTTTCTGTGTTGGCATGACCAGTCTC 
RS      GTAGAAGTACGGAAGGAAGTTTGGCAGGCTTAGTGTTTCTGTGTTGGCATGACCAGTCTC 
HS      GTAAAAGTACGGAAGGAAGTTTGGCAGGCTTAGTGTTTCTGTGTTGGCATGACCAGTCTC 
CFS     GTAAAAGTACAGAAGGAAGCTTGGCAGGCTTAGTGTTTCTGTGTTGGCATGACCAGTCTC 
AFS     GTAAAAGTACAGAAGGAAGCTTGGCAGGCTTAGTGTTTCTGTGTTGGCATGACCAGTCTC 
CSL     GTAAAAGTACAGAAGGAAGCTTGGCAGGCTTAGTGTTTCTGTGTTGGCATGACCAGTCTC 
                         
GS      TCTTCATCTTCTTCCTGGATGTAGGGCTTGGTGCCAGGGCCCCTGAGGCTCTCTCCACAA 
RS      TCTTCATCTTCTTCCTGGATGTAGGGCTTGGTGCCAGGGCCCCTGAGGCTTTCTCCACAA 
HS      TCTTCATCTTCTTCCTGGATGTAGGGCTTGGTGCCAGGGCCCCTGAGGCTTTCTCCACAA 
CFS     CCTTCCTCTTCTTCCTGGATGTAGGGCTTGGTGTTAGGGCCCCTGAAGCTTTCCCCACAA 
AFS     TCTTCCTCTTCTTCCTGGATGTAGGGCTTGGTGTTAGGGCCCCTGAAGCTTTCCCCACAA 
CSL     TCTTCCTCTTCTTCCAGGATGTAGGGCTTGGTGTTAGGGCCCCTGAAGCTTTCCCCACAA 
                                            
GS      ATAAAAGGAGGTGAAGCTGTGTGGTGCCCCCATTTCAGGTTCTTGGGGGCAGCCAAAATG
RS      ATAAAAGGAGGTGAAGCTGTGTGGTGCCCCCATTTCAGGTTCTTGGGGGCAGCCAAAATG
HS      ATAAAAGGAGGTGAAGCTGTGTGGTGCCCCCATTTCAGGTTCTTGGGGGCAGCCAAAATG
CFS     AGAAAAGGAGGTGAAGCTGTGTGGTGCCCC-ATTTCAGGTTTTTGGGGGCAGCCAAAATG
AFS     AGAAAAGGAGGTGAAGCTGTGTGGTGCCCC-ATTTCAGGTTTTTGGGGGCAGCCAAAATG
CSL     AGAAAAGGAGGTGAAGCTGTGTGGTGCCCC-ATTTCAGGTTTTTGGGGGCAGCCAAAATG
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intron 1 and is fused in frame with intron 2, causing an in-
frame deletion of 20 amino acids. Analysis of phocid seal
(ringed seal, common seal) LALBA  genomic fragments
revealed the presence of one major LALBA transcript cor-
responding to correctly spliced exons 1, 2, 3 and 4 and a
minor transcript corresponding to LALBA(Δ) (Figure 4B).
The presence of one major LALBA transcript within the
Cape fur seal mammary gland was confirmed by northern
blot analysis (Figure 4C). Expression of LALBA  was
observed to increase during lactation on-shore compared
with LALBA expression off-shore.
Otariid LALBA transcripts are not translated into protein
Previous predictions based on in silico translations of ota-
riid cDNAs suggested the protein is truncated, removing
the final 19 residues [11]. Conditioned media from cells
transfected with otariid and phocid LALBA genomic frag-
ments was tested for presence of secreted LALBA at 24 and
72 hours by western blot using a polyclonal anti-bovine
LALBA antibody. Although expression levels of otariid
and phocid LALBA transcripts were observed to be equal
due to presence of the CMV promoter (Figure 5A), and
equal amount of protein was loaded per lane and con-
firmed by coomassie blue staining of protein within the
gel (data not shown), LALBA protein was absent in the
conditioned media of cells expressing otariid seal (cape
fur seal, California sea lion, Antarctic fur seal) LALBA
genes, while LALBA protein was detected in the condi-
Table 1: Interspecies comparison of LALBA TATA box 
sequences
Species TATA box * Efficiency† Accession
Cape fur seal ‡ -58 AAGAAAA 1.2–1.5% EU295506
Sea lion ‡ -58 AAGAAAA 1.2 – 1.5% EU295508
Antarctic fur seal‡ -58 AAGAAAA 1.2 – 1.5% EU295507
Grey seal§ -59 AATAAAA 60 – 75% EU2955011
Harbour seal§ -59 AATAAAA 60 – 75% EU295509
Ringed seal§ -59 AATAAAA 60 – 75% EU2955010
Canine -59 AATAAAA 60 – 75% NC006609
Human -56 TATAAAA 100 – 172% X05153
Bovine -59 AATAAAA 60 – 75% M90645
Sheep -59 AATAAAA 60 – 75% AB040058
Camel -53 AATAAAA 60 – 75% AJ409281
Guinea pig -59 AATAAAA 60 – 75% Y00726
Goat -59 AATAAAA 60 – 75% M63868
Pig -60 AATAAAA 60 – 75% L31945
Rabbit -59 AATAAAA 60 – 75% AF123893
Water Buffalo -59 AATAAAA 60 – 75% F194373
Domestic Yak -59 AATAAAA 60 – 75% AF194372
Mouse -57 CATAAAA 60 – 75% M87863
Rat -56 AATAAAA 60 – 75% X00461
* numbers represent base pairs relative to start of translation
† prediction based on studies by Wobbe and Struhl [12] and 
expressed as a percentage of the consensus TATAAAG
‡ Otariid seal
§ Phocid seal
LALBA reporter gene expression Figure 3
LALBA reporter gene expression. (A) Cape fur seal 
(CFS), Cape fur seal TATA box mutation (CFSmut) and har-
bour seal (HS) reporter gene LALBA expression (718 bp pro-
moter) in the presence of an introduced STAT5 site in BME-
UV1 cells in the presence of insulin (I) or insulin/prolactin/
dexamethazone (IPDEX) induction. (B) Reporter gene LALBA 
expression (398 bp promoter) in the presence of a pGL3 
enhancer site in BME-UV1 and (C) HEK293T cells. Statistical 
analysis showed HS reporter gene expression in BME-UV1 
cells is significantly higher than CFS in a STAT5 background 
(P = 0.038) and also in an Enhancer background in BME-UV1 
cells (P = 0.000) and HEK239T cells (P = 0.010). Experiments 
were performed in duplicate and repeated at least twice. 
Standard errors are shown.
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tioned media of cells expressing phocid seal (ringed seal
and harbour seal) LALBA  genes (Figure 5). A crude
approximation of phocid LALBA protein production was
determined by comparison with a known bovine LALBA
(bLALBA) (10 μg) standard. Using this method approxi-
mately 0.01 μg phocid LALBA/ml was estimated to be
present within the conditioned media. Due to differences
in immunoreactivity between phocid LALBA and bovine
LALBA protein, concentrations were also calculated by
estimating the amount of LALBA within the total protein
sample. Phocid LALBA protein was not visible by coomas-
sie staining of 300 μg total protein from 1 ml conditioned
media. We can therefore conservatively estimate that
phocid LALBA is less than 10% of the total protein within
the conditioned media (0.03 mg/ml). The translation
product from the minor phocid LALBA(Δ) transcript, pre-
dicted to be 12.2 kD, was not observed.
Apoptotic effects of LALBA
We investigated the death-inducing properties of bLALBA
in the fur seal mammary gland by assaying LALBA apop-
totic potential using Cape fur seal mammary cells (Cfs-
MCs). These cells are isolated from mammary tissue and
comprise a population of epithelial cells, myoepithelial
cells and fibroblasts that have previously been shown to
form mammospheres capable of expressing milk protein
genes under induction by lactogenic hormones [16]. bLA-
LBA (0.2 to 1.6 mg/ml) was added to CfsMCs and cell
number was assessed by protein staining using an SRB
assay. Its principle is based on the ability of the protein
dye sulforhodamine B to bind electrostatically and pH-
dependently on basic amino acid residues of trichloroace-
tic acid-fixed cells. The SRB assay has been shown to be an
appropriate and sensitive assay to measure drug-induced
cytotoxicity [17]. Physiologically relevant levels of bLA-
LBA (0.6 to 1.6 mg/ml) produced a decrease in prolifera-
tion of CfsMCs in culture which was dose-dependent
(Figure 6). Cell morphology was examined after exposure
to LALBA to determine the health of the cells. CfsMCs
exhibited rounding of cells and increased detachment
from the substratum after 24 hours exposure to LALBA.
After 5 days cells exhibited shrinkage, loss of membrane
integrity and accumulation of apoptotic bodies character-
istic of the apoptosis process [18] (Figure 6D to 6I). The
decrease in cell number was therefore shown to be due to
loss of cell number, not due to decreased cell proliferation
of healthy cells. The bLALBA produced by Sigma was pre-
pared from unpasteurized milk and declared to be 99%
pure. In order to show that the observed effects were not
due to toxins or contaminants the bLALBA preparation
was heat-treated to denature the active protein (Figure
6C). Following heat treatment bLALBA lost the ability to
induce cell death, suggesting the inducing agent was of
protein origin. The doses of bLALBA inducing this effect
were observed to be equivalent to levels of LALBA nor-
mally found in the milk of most mammals [19]. Cell
death was not initiated at lower concentrations (0.2 to 0.4
mg/ml), even after an extended culture period of 14 days.
We tested the ability of bLALBA fragments to induce cell
death by digesting the preparation with pepsin. Similar to
heat treating, the apoptotic effects of bLALBA were also
reversed by pepsin digestion (Figure 6C), suggesting that
LALBA is not active as peptide fractions.
In order to determine whether bLALBA was inducing
apoptosis, as has been observed in RAW 264.7 cells [20],
we treated mouse mammary epithelial cells, HC11, with
LALBA and measured DNA fragmentation by Tunnel
staining. Increased apoptosis was observed after 1, 2 and
4 hours following LALBA treatment (Figure 7). The
number of apoptotic cells increased significantly in a
time-dependent manor (P < 0.001).
In order to show that bLALBA induces dose-dependent
apoptotic responses in other mammary epithelial cell
lines, bLALBA was added in increasing concentrations to
mouse mammary epithelial cells, HC11, and to the
human breast cancer cell line MCF-7. Similar to CfsMCs,
higher doses of bLALBA caused all cells to die, while lower
does allowed survival of a small population of cells which
went on to proliferate (Figure 8A to 8D). Morphological
examination of HC11 and MCF-7 cells following 5 days of
LALBA exposure demonstrated total loss of cellular mate-
rial. Loss of membrane integrity and cell shrinkage was
also observed, consistent with cell death pathways (Figure
8E to 8H).
Characterization of apoptotic effects
The time required for bLALBA to induce an apoptotic
response was also examined by exposing cells to bLALBA
for 1 and 8 hours and then removing bLALBA and replac-
ing with fresh media. These experiments showed apop-
totic effects of bLALBA were observed when cells were
exposed to 8 hours of bLALBA and then removed, but
apoptosis was not observed when cells were exposed for 1
hour and then removed (Figure 9).
Discussion
Specific triggers for the process of mammary involution
are unknown but autocrine feedback mechanisms have
been proposed [21]. The source of this mechanism is
thought to be factors in milk that interact with the mam-
mary epithelium and trigger involution after a period of
milk stasis. It was therefore proposed that fur seals, which
exhibit a phenotype where involution is delayed even
after very long periods of milk stasis, may lack these fac-
tors in their milk, or may lack the machinery to initiate the
involution response.BMC Biology 2008, 6:48 http://www.biomedcentral.com/1741-7007/6/48
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It has long been established that LALBA, a major milk
component, plays a central role in the mammary gland as
the regulatory subunit of lactose synthase [22]. We show
here that otariid (Cape fur seal) mammary glands express
very low levels of LALBA mRNA during the lactation cycle
compared with expression levels in other mammals,
which show LALBA is one of the most highly expressed
genes in the mammary gland during lactation [23]. LALBA
has also recently been implicated in the induction of
apoptosis of a human colon adenocarcinoma cell line
[24] and RAW264.7 cells [20]. LALBA was therefore a
likely candidate for further study in the involution proc-
ess.
Comparison of LALBA expression levels between otariid
and phocid seals showed otariid (Cape fur seal) LALBA
expression levels were very low and suggested a negligible
amount of transcription occurs from this promoter. The
low level of otariid LALBA transcription was predicted to
be due to an altered TATA box in otariid seals. All three
otariid species displayed a T-G transversion within the
third position of the TATA box creating an AAGAAA
sequence. This substitution is predicted to lead to poor
binding of the TATA binding protein and RNA polymer-
ase which are necessary for transcriptional activity [25].
The consequence of a G to T substitution in the third posi-
tion has previously been demonstrated, showing tran-
scriptional activity is reduced to 2% [12]. Correction of
this mutation in the Cape fur seal LALBA promoter failed
to increase levels of transcription, suggesting that another/
other mutations also play a role in preventing successful
transcription of LALBA. Like most pseudogenes where
evolutionary pressures are no longer required to prevent
divergence, the otariid LALBA  has likely undergone a
number of promoter mutations, which are conserved in
other lineages where LALBA is functional.
Analysis of LALBA  transcript abundance showed one
major transcript, LALBA(s) was generated for all otariid
species, with LALBA(l) and LALAB(Δ) detected as minor
LALBA transcription Figure 4
LALBA transcription. (A) RT-PCR shows equal expression of each LALBA transgene with one major mRNA transcript for 
each species. Markers are shown (bp). (B) Otariid and phocid LALBA gene structure and mRNA splice variants. The LALBA gene 
comprises four exons that undergo alternative splicing. Identified transcript variants (indicated by i, ii, iii and iv) comprise (i) a 
correctly spliced phocid LALBA transcript; (ii) an otariid LALBA transcript which is formed by use of a 3' splice site in the LALBA 
3'UTR (shown) prior to the LALBA termination codon (shown) causing a loss of exon 4; (iii) an otariid LALBA transcript which 
contains intron 3 caused by lack of splicing due to a mutation in the 3' splice site of intron 3 (mutation shown for otariid LALBA 
gene compared with correct splice sequence in phocid LALBA gene); and (iv) a transcript which is formed by use of a 5' splice 
site within exon 1 causing a 60 bp deletion of exon 1, shown here for phocid LALBA. The Otariid LALBA gene also has this 5' 
splice site (transcripts not shown here). (C) Northern blot (left panel) confirms one major LALBA transcript is detected in the 
Cape fur seal mammary gland. Right panel shows corresponding ethidium bromide-stained mRNA prior to blotting.
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transcripts. Interestingly, LALAB(Δ) was also detected in
phocid species. Other species such as dogs, humans,
sheep, rats, mice and pigs also have the same cryptic 5'
splice sequence in exon 1, suggesting the presence of
LALAB(Δ) in species other than seals.
Translation of otariid and phocid LALBA  transcripts
showed otariid LALBA mRNA failed to be translated into
secreted protein. These data are consistent with earlier
studies, which have failed to detect LALBA protein in milk
of otariid species [26,27]. These data suggest the predicted
translation of two isoforms of truncated LALBA protein
(Reich and Arnould [11]) are incorrect. The authors sug-
gest this is the mechanism for lack of lactose in fur seal
milk and that lack of lactose as a major milk osmole has
facilitated the fur seal lactation strategy and prevented
engorgement while at sea. Contrary to this, it has been
postulated elsewhere that other osmoles are present in
otariid milk, such as Fuc(α1–2)Gal(β1–4)Glc, which is
also found in related species of the order Carnivora [28].
These trisaccharides may provide an alternative osmotic
mechanism to move water from the extracellular fluid
into the milk. All these species have only small amounts
or no lactose relative to oligosaccharides. Myo-inositol
and free amino acids are also found at high concentra-
tions in otariid milk [5] and exceptionally high concentra-
tions of taurine are found in Pinnipeds [29]. Therefore, it
is likely myo-inositol and taurine may play a significant
role as organic osmolites. There are other examples in
nature where lactose is not required for milk production.
In tammar wallaby (Macropus eugenii) milk, carbohydrate
is low and lactose is absent throughout peak lactation
[30], during which time other unknown factors act as the
major osmole, demonstrating that lactose is not necessary
for milk production in some species. The high level of
milk production by fur seals lactating on-shore ultimately
requires the presence of an osmole, be it trisaccharides or
organic osmolites, while the absence of engorgement in
fur seal mammary glands while at sea is likely the result of
reduced milk production by downregulation of milk syn-
thesis at the transcriptional level [8].
Evidence presented here shows that bLALBA causes apop-
tosis of mouse and human mammary epithelial cell lines
and fur seal primary mammary cells, demonstrating that
although LALBA is absent in fur seal milk, the LALBA-
mediated apoptotic pathway is still intact in fur seal mam-
mary cells. It is interesting to note that all cell types in the
Cape fur seal mammary population responded to bLA-
LBA, suggesting that the apoptotic response to LALBA is
not limited to epithelial cells, but also affects other cells
types such as fibroblast and myoepithelial cells. The loss
LALBA translation Figure 5
LALBA translation. LALBA immunoreactive protein from 
supernatants, collected 24 hours after transfection of expres-
sion constructs shows non-glycosylated (non), mono-glyco-
sylated (mono) and double glycosylated (double) forms of 
phocid LALBA, while otariid LALBA was not detected. Mark-
ers are shown (kD).
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bLALBA effects on CfsMCs Figure 6
bLALBA effects on CfsMCs. (A) CfsMCs exposed to 
bLALBA or (B) BSA l0 mg/ml, m0.2 mg/ml, 0.4 mg/ml, h0.8 
mg/ml, s1.6 mg/ml. (C) Loss of bLALBA activity by heat treat-
ment or pepsin digestion l1 mg/ml LALBA heat treated, h1 
mg/ml BSA, m1 mg/ml LALBA, l1 mg/ml LALBA with pepsin 
digestion. (D) Morphology of CfsMCs exposed to bLALBA 
shows cells relinquish contact and detach from the substra-
tum after 24 hours causing their rounding (white arrows). 
(E) After 2 days and (F) 5 days of bLALBA exposure cells 
exhibited shrinkage, loss of cell membrane integrity and 
membrane blebbing (black arrows) and accumulation of 
apoptotic bodies (black arrowheads). (G) CfsMCs exposed 
to 1 mg/ml BSA after 24 hours (H) 2 days and (I) 5 days. 
Scale represents 100 μm.
0.0
0.3
0.6
0.9
1.2
1471 0 1 3
A
b
s
 
5
5
0
n
m
Days
1471 0 1 3123456
ABC
H G
F E D
IBMC Biology 2008, 6:48 http://www.biomedcentral.com/1741-7007/6/48
Page 10 of 15
(page number not for citation purposes)
of LALBA apoptotic activity by heat treatment confirms
the active component is of protein origin and suggests the
apoptotic effects observed do not occur when the protein
is fragmented by digestion with pepsin. Previously a mul-
timeric form of LALBA (MAL), isolated from the casein
fraction of human milk and formed by low pH treatment
and ion-exchange, has been shown to reduce cell viability
in kidney, intestine, bladder, lung cell lines, lymphocytes
and thymocytes, but healthy cells were not affected [31]
and mammary epithelial cells were not tested. HAMLET
(human α-lactalbumin made lethal to tumour cells) [32],
which is chemically treated to resemble MAL in structure,
bLALBA apoptosis rate Figure 7
bLALBA apoptosis rate. Apoptotic HC11 cells (brown) 
are shown. (A) 0 mg/ml LALBA, (B) 1 mg/ml LALBA/1 hour, 
(C) 1 mg/ml LALBA/2 hour, and (D) 1 mg/ml LALBA/4 hour 
treatments. Scale bars represent 20 μm. (E) The percentage 
of apoptotic cells increased significantly (P < 0.001) for each 
time point versus the control.
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bLALBA dose-dependent effects on HC11 and MCF-7 cells Figure 8
bLALBA dose-dependent effects on HC11 and MCF-
7 cells. (A-B) HC11 and (C – D) MCF-7 cells exposed to 
BSA (A and C) or bLALBA (B and D). l0 mg/ml, m0.2 mg/ml, 
n0.4 mg/ml, h0.8 mg/ml, s1.6 mg/ml. (E and F) Morphology of 
HC11 and (G and H) MCF-7 cells grown for 14 days in 1.6 
mg/ml BSA (E and G) or 1.6 mg/ml bLALBA (F and H). Scale 
bars represent 100 μm.
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is a complex of apo-LALBA combined with oleic acid. The
oleic acid co-factor binding of HAMLET is very unstable
and is easily displaced by foetal calf serum (FCS). All
apoptosis-inducing experiments involving HAMLET need
to be performed in the absence of FCS, unlike the experi-
ments presented here, which show LALBA inducing apop-
tosis in the presence of 10% FCS, suggesting that the
LALBA in the current study is different in structure to
HAMLET. HAMLET has been shown to localize to the
nucleus where it binds to histones, disrupts chromatin
structure and leads to cell death [33]. It has also been
shown that negatively charged untreated LALBA can also
bind to positively charged histones without the aid of
oleic acid, causing aggregation [34] and suggesting that
other natural forms of LALBA can induce apoptosis as
observed in the current study. Indeed, untreated bLALBA
has previously been found to have an apoptotic effect on
cell types other than mammary cells. LALBA has previ-
ously been shown to induce apoptosis in human colon
adenocarcinoma cell lines [24] and RAW264.7 cells [20]
using the same bLALBA preparations from Sigma [20].
Analysis in RAW2.64.7 cells showed cells exposed to bLA-
LBA exhibited cell shrinkage, disruption of cellular mem-
branes, accumulation of apoptotic bodies, DNA
fragmentation, an increase in sub-G1 cells, increased
Annexin V expression and activation of caspase 3 [20].
These results are characteristic of the apoptotic process
and show that bLALBA indeed induces a programmed cell
death response via apoptosis. Similarly, we have also
observed cell shrinkage, disruption of cellular mem-
branes, accumulation of apoptotic bodies and DNA frag-
mentation in this study using mammary cells following
exposure to bLALBA. We have also observed an increase in
caspase 3 expression following exposure of HC11 cells to
bLALBA for 5 hours (Brennan et al, manuscript in prepa-
ration), suggesting the same apoptotic pathway is acti-
vated in mammary cells as in RAW264.6 cells. In the
current study we expressed phocid LALBA in HC11 cells
without observing apoptosis of the host cell. Although
expression of the transgene was observed to be high due
to the presence of a CMV promoter, the amount of protein
collected in the conditioned medium was determined to
be less than that required for effective LALBA-induced
apoptosis. In addition, stably transfected cells have been
derived which express bLALBA which are also not detri-
mentally affected [35]; we suggest that these cell lines are
also not capable of producing the high concentration of
LALBA (0.2 to 1.6 mg/ml) necessary for induction of
apoptosis.
Our data suggest that low levels of LALBA may not cause
apoptosis in the in vivo epithelium. It could be postulated
that LALBA acts only at a critical concentration and
requires a specific amount of time in contact with the cell,
or undergoes a conformational change during milk stasis
in order to elicit its apoptotic potential. Involution only
occurs following milk stasis and it has been previously
demonstrated that LALBA concentrations increase in milk
during mammary gland involution, while other milk pro-
teins show decreases in concentration [36]. LALBA may
cause limited apoptosis in the in vivo epithelium during
lactation, as seen by decreased milk production in cows as
lactation proceeds [37]. This gradual reduction in milk
production over the lactation period has been referred to
Cape fur seal mammary cells require extended exposure of  bLALBA for induction of apoptosis Figure 9
Cape fur seal mammary cells require extended expo-
sure of bLALBA for induction of apoptosis. (A – D) 1 
mg/ml bLALBA was added to CfsMCs for 1 hour, LALBA was 
then washed out and fresh media was added. (E – H) For 
comparison, 1 mg/ml LALBA was added to cell culture media 
and allowed to remain on the cells. Cells were photographed 
at day 1 (A and E), day 2 (B and F), day 4 (C and G) and day 
5 (D and H). Scale bars represent 100 μm.
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as 'gradual involution'. In fur seals milk production does
not decline as in other mammals, but has been shown to
increase as the pup grows larger. This is presumed to sus-
tain the nutritional needs of a growing pup. The lack of
LALBA in fur seals may not only allow these mammals to
circumvent involution, but may also aid in avoiding grad-
ual involution observed in other lactating mammals.
We suggest that exposure of mammary epithelial cells to
LALBA may be a mechanism for mammary gland involu-
tion during milk stasis at weaning, a time when LALBA
levels increase in the milk. To support this we have pre-
sented a molecular analysis of a relevant lactation model,
the fur seal, which avoids involution in the presence of
milk stasis and showed that these animals do not produce
LALBA in their milk. In addition we have shown that
mammary epithelial cells, when exposed to similar LALBA
concentrations to those found in milk, undergo an apop-
totic response.
Conclusion
We propose that mammary gland involution does not
normally occur in fur seal mammary glands due to
absence of LALBA in fur seal milk and not due to the pres-
ence of a truncated LALBA protein as previously reported
[11]. The absence of LALBA has therefore facilitated the
divergence of the fur seal species during evolution and
enabled this species to adopt a unique lactation pheno-
type to exploit their environment. This hypothesis is sup-
ported by previous observations of LALBA-deficient mice
[38]. Milk of LALBA-deficient mice [38] is high in lipid
and protein but very low in lactose; however, mothers are
not capable of feeding their young as milk is highly vis-
cous and cannot be removed by normal suckling. Mice,
unlike fur seals, rely on lactose as their major osmole and
therefore milk in this mouse was devoid of water, making
sucking-induced removal of milk from the mammary
gland impossible. After 5 days of lactation, alveoli of
LALBA-deficient mouse mammary glands were distended
and so engorged with milk that tight junctions were com-
promised and milk was observed to move from the alveo-
lar space and enter into the surrounding mammary tissue.
However, there was no evidence of apoptosis or involu-
tion which would normally occur by this time in the
absence of milk removal [39]. The absence of apoptosis
and involution in the LALBA-deficient mouse is consistent
with absence of apoptosis and involution in the LALBA-
deficient otariid seal.
The tammar wallaby is another model species with an
unusual LALBA phenotype. As discussed previously, wal-
laby milk during peak lactation is devoid of lactose; how-
ever, LALBA is secreted in wallaby milk at similar levels to
other mammals throughout lactation [30]. Examination
of expression levels of wallaby LALBA in the current study
showed similar levels to other mammals such as pig and
mice during peak lactation. This shows that wallabies
have uncoupled secretion of LALBA and lactose produc-
tion. In contrast to fur seals, wallabies do not have an
interrupted pattern of lactation and do not have long peri-
ods of non-suckling activity, so we predict that continued
secretion of LALBA during wallaby lactation is required
solely for rapid initiation of mammary gland involution
at weaning.
Here we show that LALBA acts an as apoptotic inducer of
mammary epithelial cells and we correlate the lack of
LALBA with the absence of apoptosis in fur seal mammary
glands. This study has shown how lack of LALBA has had
important evolutionary consequences leading to the phe-
notypic trait of foraging lactation in fur seals that is differ-
ent from the fasting lactation in phocid seals, and by
doing so identifies LALBA as a likely candidate trigger for
involution in the mammary gland.
Methods
RNA preparation
RNA was isolated (QIAGEN RNeasy Lipid Kit, Australia)
from Cape fur seal, wallaby, pig and mouse mammary tis-
sue or from cells derived from California sea lion and Ant-
arctic fur seal milk during peak lactation, human milk and
colostrum at 24 hours prior to birth and at 3 and 4
months peak lactation, or HEK293T cells. mRNA purifica-
tion was performed by NucleoSpin kit (BD Biosciences).
Microarray analysis
RNA isolated from Cape fur seal mammary glands during
pregnancy (n = 2), on-shore lactation (n = 2) and offshore
foraging (n = 1) or human during pregnancy (n = 2) and
lactation (n  = 2) was used for gene profiling analysis.
Labelling of RNA and microarray processing was con-
tracted to the Australian Genome Research Facility (Mel-
bourne, Australia) using Canine genome 2.0 or Human
genome Affymetrix genechips. Cow Affymetrix results
were kindly provided by Dr PA Sheehy, Faculty of Veteri-
nary Science, University of Sydney, NSW, Australia. Data
was normalized using RMA methods in Bioconductor
[40]. Mouse Affymetrix results were obtained from http://
breast-cancer-research.com/content/6/2/R92[39].
Off-shore Cape fur seal EST library
mRNA (1 μg) was used to construct a cDNA library using
Creator SMART cDNA Library Construction Kit (BD Bio-
sciences). A total of 11,232 ESTs were sequenced by the
Australian Genome Research Facility, Brisbane, Australia.
RT-PCR
Total RNA (0.1 μg) was used to create cDNA. 0.2 μl cDNA
was used in PCR with 20, 25 and 30 cycles of amplifica-
tion to determine the linear range. Each PCR was per-BMC Biology 2008, 6:48 http://www.biomedcentral.com/1741-7007/6/48
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formed at least twice. See additional file 1: supplementary
Table 1 for primer sequences. Images of PCR products
resolved in ethidium bromide-stained agarose gels were
visualized using UVP BIODoc-it System (Pathtech, Aus-
tralia) and saved by PCTV Vision software. Quantification
was performed by densitometry using ImageJ software
(NIH). Expression levels were estimated by normalizing
expression against GAPDH.
Northern blotting
mRNA (1 μg) was electrophoresed in 1.2% agarose gels,
blotted to Zeta Probe and hybridized with a 32P-labelled
Cape fur seal LALBA cDNA probe (550 bp).
Genomic LALBA expression constructs
DNA was extracted from Cape fur seal liver and California
sea lion and Antarctic fur seal milk. DNA from ringed seal,
grey seal and harbour seal were gifts from Dr P Johnson
(Ohio University, USA), Dr M Walton (University of St.
Andrews, Scotland) and Dr N Lehman (Portland State
University, USA), respectively. LALBA coding sequences
were amplified using specific primers spanning the ATG
of exon 1 and 3' UTR (Additional file 1: supplementary
Table 1). Amplified products were cloned into pTarget
(Promega) and sequenced. Fragments in incorrect orien-
tation were digested using NotI and XhoI restriction sites
flanking the LALBA  fragment and were cloned into
pcDNA3.1 (Promega) and sequenced. Both vectors con-
tain CMV promoters and all constructs contained a Kozak
sequence A/GTGATTATGA. Cape fur seal, Antarctic fur
seal, and harbour seal LALBA were cloned into pTarget,
while ringed seal and sea lion DNA were cloned into
pcDNA 3.1.
Reporter constructs
LALBA 5' promoter sequences were amplified using prim-
ers corresponding to -770 bp to -750 bp and -12 bp to +3
bp containing an NcoI restriction site. Amplified DNA was
cloned into pGemt-easy (Promega) and sequenced. Muta-
genesis of TATA box and STAT5 sites was performed by
PCR and sequenced. Plasmids were digested with NcoI/
SacI using sites within the vector and 718 bp and 398 bp
fragments were subcloned into pGL3-basic and pGL3-
enhancer respectively and sequenced. See additional file
1: supplementary Table 1 for primers.
Preparation of Cape fur seal mammary cells
Mammary tissue was obtained from one Cape fur seal,
which was confirmed to be pregnant and non-lactating
from inspection of the uterus and mammary glands,
respectively. Tissue was immediately transferred to 1×
Hanks' Balanced Salt Solution (HBSS) (Sigma Aldridge,
Sydney, Australia) with 10 μl/ml penicillin/streptomycin
(Gibco, USA) and 2.5 μg/ml Fungizone (Gibco, USA) on
ice and transported back to the laboratory for enzymatic
digestion to harvest mammary epithelial cells. Mammary
tissue was dissected free from fat, weighed, sliced finely
and digested with collagenase and hyaluronidase (25 g
tissue per 100 ml media) at 37°C for 4 hours. Cells were
harvested by filtration (Nalgene filter, 53 μm and 200 μm
mesh). The suspension was centrifuged 80 g/5 minutes,
pellets were washed twice with HBSS. Cell suspensions
were centrifuged, resuspended in M199 and 90% FCS/
10% DMSO (DMSO-Sigma, Sydney, Australia), and fro-
zen at a density of ~2 × 107 cells/ml.
Cape fur seal mammary cells were cultured in either 25 or
80 cm2 culture flasks in 5 ml or 10 ml respectively of
M199/Hams/Hepes media with 1 μg/ml cortisol, 10 ng/
ml EGF, 1 μg/ml insulin supplemented with 20% horse
serum and 5% foetal bovine serum. The cells were pas-
saged (up to three times) when confluent using 0.1%
trypsin-versine solution in phosphate buffered saline
(Sigma-Aldrich, Sydney, Australia).
Cell culture
HEK293T and MCF-7 were grown in DMEM/10% FCS,
HC11 cells were grown in M199/HAMS/HEPES/10% FCS,
CfsMCs were grown in M199/HAMS/HEPES/20% horse
serum/5% FCS with 1 μg/ml cortisol, 10 ng/ml EGF, 1 μg/
ml insulin (I) and BME-UV1 cells were grown in 50%
DMEM/30% RMPI/20% NCTC-135/5% FCS with 1.0%
lactose, 0.1% lactalbumin hydrolysate, 1.2 mM glutath-
ione, 5 μg transferrin/ml, 10 μg L-ascorbic acid/ml. For
induction, BME-UV1 media was supplemented with I (1
μg/ml), prolactin (P) (1 μg/ml), dexamethazone (Dex) (1
μM).
Transfection
Prior to transfection BME-UV1 cells were induced for 24
hours with I or I, P, Dex. Transfection was performed
using lipofectamine (Invitrogen). Reporter constructs
were co-transfected with β-glycosidase vector. Induction
or growth media was replaced after 6 hours and incubated
for 2 days. For LALBA  transcript and protein analysis
media was changed to DMEM/2% FCS and incubated for
72 hours. Media was collected at 24 and 72 hours. After 72
hours RNA was isolated.
Assays
Luciferase assays were performed using Luciferase Assay
reagent (Promega, USA) and β-glycosidase assays were
performed according to the β-galactosidase Enzyme and
Assay System with Reporter Lysis Buffer Kit (Promega,
USA). Luciferase expression values were normalized by
comparison with β-glycosidase activity. Each experiment
was performed in duplicate and repeated at least twice.BMC Biology 2008, 6:48 http://www.biomedcentral.com/1741-7007/6/48
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Western blot
1 ml of conditioned media (24 and 72 hours) was washed
free from salts by use of Amicon ultra 1 kD columns (Mil-
lipore). Supernatants were concentrated and resuspended
in 50 μl dH2O and assayed for protein by BCA assay
(Pierce, Rockford, IL). 300 μg protein (~50 μl) was sepa-
rated on 15% SDS-PAGE gel and transferred to PVDF
membrane. Coomassie staining of the gel confirmed an
equal amount of protein was loaded per sample. Immu-
noblotting was conducted by using rabbit polyclonal anti-
bodies specific for LALBA, detected with a goat anti-rabbit
HRP-conjugated antibody (Pierce), and visualized using
SuperSignal chemiluminescent substrate (Pierce, Rock-
ford, IL). The experiment was performed in triplicate
using two time points per sample.
Proliferation assay and cell morphology
Cells were plated (2000 cells/well) in 96-well plates in
growth media supplemented with 10% FCS. After one day
bLALBA (SIGMA, Australia) was added and cells were
grown for 2, 4, 6, 8, 10, 12 and 14 days before fixing and
staining with Sulforhodamine B. Cells were visualized by
phase contrast microscopy on corresponding days using
an Olympus BX40 microscope and photographed using a
DigitalSight DSL1 (Nikon) camera. Each experiment was
performed on three separate occasions in quadruplicate.
Heat treatment was performed at 95°C for 10 minutes.
Pepsin digestion was performed with 1.5 mg bLALBA in
HCl (pH 2) 1:500 enzyme to substrate for 60, 90 or 120
minutes/37°C. Products were purified using 1 kD Centrif-
ugal device (Amicon Ultra). Products of digestion were
analyzed on SDS-page gels.
In situ detection of apoptosis
Mouse mammary epithelial cells, HC11, (1 × 105 cells per
glass chamber slide) were plated and allowed to grow
overnight in growth media. The following day media was
removed and cells were treated in duplicate with 1 mg/ml
bLALBA in growth media for 1, 2 and 4 hours or 0 mg/ml
bLALBA. Apoptotic cells were detected using Apotag Per-
oxidase in situ Apoptosis Detection kit (Chemicon, Aus-
tralia), according to the manufacturer's instructions for
staining of cultured cells. Slides were counterstained with
0.5% methyl green and mounted using aqueous mount-
ing medium. The apoptotic cells (brown staining) were
viewed and counted using an Olympus BX50 microscope
for light microscopy. The apoptotic index was defined by
the percentage of brown (dark) cells among the total
number of cells in each sample. For each treatment five to
eight random fields were used to count apoptotic and live
cells. A total of 711 cells (0 mg/ml LALBA), 587 cells (1
mg/ml bLALBA/1 hour), 473 (1 mg/ml bLALBA/2 hours)
and 434 cells (1 mg/ml bLALBA/4 hours) were counted
for each treatment. Results are represented as percentage
of apoptotic and live cells.
Statistics
For expression analysis unpaired student t-tests using 6
degrees of freedom were used to determine statistical sig-
nificance. For apoptotic analysis a 2-tailed student t-test
was used. Each test incorporated data from two independ-
ent experiments performed in duplicate on separate days.
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